NICE INSIGHT REPORT
Microbial Fermentation, Biologics:Market Insight, CDMO Pricing and Benchmarking
UPDATED MONTHLY
2025 CDMO pricing data for 101 clinical and commercial microbial biologics development and manufacturing RFP service line items
Exhaustive directory of capabilities profiles for the top 44 biologics CDMOs specializing in microbial fermentation
Technical focus on the regulatory landscape and manufacturing challenges for biologics, such as GLP-1 and insulin trials, cytokines, and growth factors
Includes Nice Insight's Clinical Trials Landscape tool — an in-depth custom research platform for current and upcoming microbial biologics trials, sourced from the FDA Clinical Trials Database
Key market insights for innovators, CDMOs, and investors in the microbial biologics industry. Mix and match subscriptions to fit your organization's goals.
Trends & Opinions
Immediate access to Nice Insight's Microbial Biologics Trends & Opinions section — our SMEs' analysis of where the market is now and where it's headed.
Clinical Trials Landscape
Access to Nice Insight's Microbial Biologics Clinical Trials report, plus access to our multi-modality Clinical Trial Landscape tool — an in-depth, interactive study of current and upcoming microbial biologics trials.
Our Market Insight provides preclinical-through-commercial research, data and analysis from Ph.D. scientists and respected voices in biopharma.
Master the Microbial Biologics Market, Preclinical through Commercial:
Competitive Benchmarking
50+ Microbial CDMO Profiles
Over 1,000 hours of data collection and analysis —
including interviews with CDMO owners, PhDs and customers.
